185 related articles for article (PubMed ID: 21574291)
1. [Assessment of the results of 24-hour arterial pressure monitoring in patients with arterial hypertension treated with fixed combinations of co-renitec and gyzaar with and without acupuncture reflexotherapy].
Kudriavtsev AA; Riazanov AS; Eremenko NN
Vopr Kurortol Fizioter Lech Fiz Kult; 2011; (2):5-7. PubMed ID: 21574291
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
3. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Avanza AC; El Aouar LM; Mill JG
Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
[TBL] [Abstract][Full Text] [Related]
4. [Combined treatment of arterial hypertension (results of the international program CLIP-ACCORD)].
Chazova IE; Ratova LG
Ter Arkh; 2009; 81(5):60-4. PubMed ID: 19537589
[TBL] [Abstract][Full Text] [Related]
5. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of hypertension in general practice with Renitec and Co-Renitec--analysis of an administration study].
Magometschnigg D; Hitzenberger G
Wien Med Wochenschr; 1996; 146(24):624-8. PubMed ID: 9123950
[TBL] [Abstract][Full Text] [Related]
7. [Co-renitek treatment of patients with moderate and severe forms of hypertensive disease].
Chazova IE; Ratova LG; Dmitriev VV; Khanbalaeva MN; Kotkina TI
Ter Arkh; 2003; 75(8):21-6. PubMed ID: 14520845
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
[TBL] [Abstract][Full Text] [Related]
9. [Fixed-combination of losartan/hydrochlorothiazide 100 mg/25 mg. Tolerability and efficacy on blood pressure measured in the practice and for 24 hours].
Förster A; Smolka W; Jung C; Bestehorn K
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():111-8. PubMed ID: 17955788
[TBL] [Abstract][Full Text] [Related]
10. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
[TBL] [Abstract][Full Text] [Related]
11. An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension.
Chowta KN; Chowta MN; Bhat P; Adhikari PM
J Assoc Physicians India; 2002 Oct; 50():1236-9. PubMed ID: 12568205
[TBL] [Abstract][Full Text] [Related]
12. A comparative evaluation of therapeutic effects of once a day dose of losartan potassium versus enalapril maleate in mild to moderate essential hypertension.
Neki NS; Arora P
J Indian Med Assoc; 2001 Nov; 99(11):640-1. PubMed ID: 12022207
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of hypotensive effect in patients with arterial hypertension and desaturation signs of obstructive sleep apnea syndrome during sleep].
Zelveian PA; Oshchepkova EV; Buniatian MS; Rogoza AN
Ter Arkh; 2004; 76(6):81-4. PubMed ID: 15332583
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the evenness of the antihypertensive effect of losartan and captopril by using a 24-hour monitoring of arterial pressure].
Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
Ter Arkh; 2001; 73(2):38-43. PubMed ID: 11338852
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
[TBL] [Abstract][Full Text] [Related]
17. [Experience in using acupuncture reflexotherapy combined with weight-reducing diet therapy in hypertension].
Vukolova ZP; Oganova AG; Sukhanova MV
Ter Arkh; 1998; 70(8):41-5. PubMed ID: 9770743
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor.
Weir MR; Lavin PT; Byrnes CA
Clin Ther; 1993; 15(3):527-38. PubMed ID: 8364944
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
Abe M; Okada K; Matsumoto K
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
[TBL] [Abstract][Full Text] [Related]
20. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
